How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World: Perspectives from 11 Countries

How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World: Perspectives from 11 Countries

Coronavirus illness 2019 (COVID-19) introduced the world to its knees. As every nation grappled with launching an efficient response whereas concurrently minimizing repercussions on well being care techniques, economies, and societies, the medical and scientific panorama shifted perpetually.
Particularly, COVID-19 has challenged and remodeled the sphere of dermatology and the best way we observe. On this article, dermatologists from 11 nations share insights gained from native expertise. These international views will assist present a greater framework for delivering high quality dermatologic care and understanding how the sphere has advanced throughout this medical disaster.

Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Illness

Many pores and skin manifestations of extreme acute respiratory syndrome coronavirus-2 (SARS-CoV-2) an infection replicate activation of cutaneous and systemic immune responses involving effector pathways of each the innate and adaptive arms of the immune system.
This text evaluations proof from the current scientific and scientific literature that informs the present understanding of the implications of coronavirus illness 2019 (COVID-19)-induced immune cell activation, as related to dermatology. Subjects embody the scientific penalties of autoantibody manufacturing in sufferers with COVID-19, immunologic proof for chilblains as a manifestation of SARS-CoV-2 an infection, and the connection between kind I interferons and COVID-19 illness severity.

The consequences of Alzheimer’s and Parkinson’s illness on 28-day mortality of COVID-19

We in contrast the prognosis of inpatients with a recognized prognosis of Alzheimer’s or Parkinson’s illness who’ve COVID-19 an infection with different hospitalized sufferers with COVID-19. Our cohort research began in October 2020 and resulted in Could 2021 and included inpatients with COVID-19 an infection who have been admitted to hospitals.
From a complete of 67,871 sufferers with a confirmed prognosis of COVID-19, a pattern of 3732 people have been chosen of which 363 had Alzheimer’s, and 259 had Parkinson’s illness. All sufferers had each optimistic RT-PCR check and optimistic chest CT for COVID-19. The result was useless inside 28 days of admission and the predictors have been a lot of demographic and scientific options, and comorbidities recorded at sufferers’ bedside. Mortality have been 37.5%, 35.1%, and 29.5% in sufferers with Alzheimer’s illness, Parkinson’s illness; and in different sufferers, respectively.
The hazard ratio for Alzheimer’s illness was 1.27 (95% CI, 1.06-1.53, p=0.010) and for Parkinson’s illness was 1.17 (95% CI, 0.94-1.46, p=0.171). Age was a predictor of mortality, hazard ratio=1.04 (95% CI, 1.03-1.05, p<0.001). Sufferers with Alzheimer’s illness and COVID-19 an infection have been older and extra more likely to have a lack of consciousness on admission (each p≤0.001).
We concluded that inpatients with Alzheimer’s illness have an elevated danger for 28-day mortality from COVID-19 and healthcare settings needs to be prepared to supply vital take care of them akin to early intubation and fast O2 remedy. Nonetheless, Parkinson’s illness doesn’t considerably predict larger mortality of COVID-19.

Hormone remedy and cardiovascular illness: Advantages and harms

Menopause transition marks an vital section in life when cardiovascular danger in girls regularly takes an antagonistic flip. Though menopausal hormone remedy has gained a damaging appreciation during the last a long time, its worth within the remedy of disabling vasomotor signs continues to be undisputed. Cardiovascular danger evaluation has change into a matter of precision medication, which is useful for protected menopausal hormone remedy prescription. With a multidisciplinary strategy the present accessible hormone regimens will be even given to girls at intermediate cardiovascular danger, when danger elements akin to hypertension and dyslipidemia are adequately monitored and handled.

Publish-Transplant Cardiovascular Illness

Heart problems stays a number one reason behind demise and morbidity in kidney transplant recipients and a standard cause for post-transplant hospitalization. A number of conventional and nontraditional cardiovascular danger elements exist, and plenty of of them current pretransplant and worsened, partly, as a result of addition of immunosuppression post-transplant.
We talk about optimum methods for identification and remedy of those danger elements, together with the rising function of sodium-glucose cotransporter 2 inhibitors in post-transplant diabetes and heart problems. We current widespread sorts of heart problems noticed after kidney transplant, together with coronary artery illness, coronary heart failure, pulmonary hypertension, arrhythmia, and valvular illness.
We additionally talk about screening, remedy, and prevention of post-transplant cardiac illness. We spotlight areas of future analysis, together with the necessity for targets and greatest medicines for danger elements, the function of biomarkers, and the function of screening and intervention.

Coronavirus Illness 2019 and Dermatology Observe Modifications

The influence of the COVID-19 pandemic on dermatology observe can’t be overstated. At its peak, the pandemic resulted within the short-term closure of ambulatory websites as assets have been reallocated in direction of pandemic response efforts.
Many outpatient clinics have since reopened and are starting to expertise a semblance of pre-pandemic routine, albeit with restrictions in place. We offer an outline of how COVID-19 has affected dermatology observe globally starting with the rise of teledermatology. A abstract of knowledgeable suggestions that form the “new regular” in varied domains of dermatology observe, specifically, dermatology session, procedural dermatology, and phototherapy, can be supplied.

Power kidney illness measures for cardiovascular danger prediction

Power kidney illness (CKD) impacts 15-20% of adults globally and causes varied issues, some of the vital being heart problems (CVD). CKD has been related to many CVD subtypes, particularly extreme ones like coronary heart failure, unbiased of potential confounders akin to diabetes and hypertension.
There is no such thing as a consensus in main scientific tips as to how one can incorporate the 2 key measures of CKD (glomerular filtration price and albuminuria) for CVD danger prediction. It is a vital missed alternative to appropriately refine predicted danger and personalize prevention therapies in line with CKD standing, notably since these measures are sometimes already evaluated in scientific care.

DSCAM antibody

70R-6114 50 ug
EUR 467
Description: Rabbit polyclonal DSCAM antibody raised against the middle region of DSCAM

DSCAM Antibody

1-CSB-PA007192LA01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against DSCAM. Recognizes DSCAM from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:200-1:500

anti-Dscam

YF-PA23605 50 ul
EUR 334
Description: Mouse polyclonal to Dscam

DSCAM Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV666679 1.0 ug DNA
EUR 3085

DSCAM Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV666683 1.0 ug DNA
EUR 3085

DSCAM Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV666684 1.0 ug DNA
EUR 3085

Dscam ORF Vector (Rat) (pORF)

ORF066231 1.0 ug DNA
EUR 2196

Dscam ORF Vector (Mouse) (pORF)

ORF043366 1.0 ug DNA
EUR 2196

DSCAM ORF Vector (Human) (pORF)

ORF018532 1.0 ug DNA Ask for price

DSCAM Polyclonal Antibody

ES11032-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against DSCAM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

DSCAM Polyclonal Antibody

ES11032-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against DSCAM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

DSCAM Polyclonal Antibody

ABP58424-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from part region of human DSCAM protein
  • Applications tips:
Description: A polyclonal antibody for detection of DSCAM from Human, Mouse, Rat. This DSCAM antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DSCAM protein

DSCAM Polyclonal Antibody

ABP58424-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from part region of human DSCAM protein
  • Applications tips:
Description: A polyclonal antibody for detection of DSCAM from Human, Mouse, Rat. This DSCAM antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DSCAM protein

DSCAM Polyclonal Antibody

ABP58424-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from part region of human DSCAM protein
  • Applications tips:
Description: A polyclonal antibody for detection of DSCAM from Human, Mouse, Rat. This DSCAM antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DSCAM protein

DSCAM Polyclonal Antibody

A69471 100 ?g
EUR 628.55
Description: The best epigenetics products

DSCAM Blocking Peptide

33R-6387 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DSCAM antibody, catalog no. 70R-6114

Anti-DSCAM antibody

STJ70978 100 µg
EUR 359

Anti-DSCAM antibody

STJ192190 200 µl
EUR 197
Description: Unconjugated Rabbit polyclonal to DSCAM

DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723365 1.0 ug DNA Ask for price

DSCAM-AS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723369 1.0 ug DNA Ask for price

DSCAM-AS1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723370 1.0 ug DNA Ask for price

DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV723371 1.0 ug DNA Ask for price

DSCAM-IT1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV723375 1.0 ug DNA Ask for price

DSCAM-IT1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV723376 1.0 ug DNA Ask for price

DSCAM-AS1 ORF Vector (Human) (pORF)

ORF018533 1.0 ug DNA Ask for price

DSCAM-IT1 ORF Vector (Human) (pORF)

ORF018534 1.0 ug DNA Ask for price

Rat DSCAM shRNA Plasmid

20-abx987696
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg
  • Shipped within 15-20 working days.

DSCAM ELISA KIT|Human

EF004874 96 Tests
EUR 689

Mouse Dscam ELISA KIT

ELI-47169m 96 Tests
EUR 865

Human DSCAM shRNA Plasmid

20-abx951275
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg
  • Shipped within 15-20 working days.

Mouse DSCAM shRNA Plasmid

20-abx970065
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg
  • Shipped within 15-20 working days.

DSCAM Antibody, HRP conjugated

1-CSB-PA007192LB01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against DSCAM. Recognizes DSCAM from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

DSCAM Antibody, FITC conjugated

1-CSB-PA007192LC01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against DSCAM. Recognizes DSCAM from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

DSCAM Antibody, Biotin conjugated

1-CSB-PA007192LD01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 >95%, Protein G purified
Description: A polyclonal antibody against DSCAM. Recognizes DSCAM from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

DSCAM Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV666680 1.0 ug DNA
EUR 3085

DSCAM Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV666681 1.0 ug DNA
EUR 3143

DSCAM Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV666682 1.0 ug DNA
EUR 3143

DSCAM Protein Vector (Human) (pPB-C-His)

PV074125 500 ng Ask for price

DSCAM Protein Vector (Human) (pPB-N-His)

PV074126 500 ng Ask for price

DSCAM Protein Vector (Human) (pPM-C-HA)

PV074127 500 ng Ask for price

DSCAM Protein Vector (Human) (pPM-C-His)

PV074128 500 ng Ask for price

DSCAM Protein Vector (Mouse) (pPB-C-His)

PV173462 500 ng
EUR 3319

DSCAM Protein Vector (Mouse) (pPB-N-His)

PV173463 500 ng
EUR 3319

DSCAM Protein Vector (Mouse) (pPM-C-HA)

PV173464 500 ng
EUR 3319

DSCAM Protein Vector (Mouse) (pPM-C-His)

PV173465 500 ng
EUR 3319

DSCAM Protein Vector (Rat) (pPB-C-His)

PV264922 500 ng
EUR 3319

DSCAM Protein Vector (Rat) (pPB-N-His)

PV264923 500 ng
EUR 3319

DSCAM Protein Vector (Rat) (pPM-C-HA)

PV264924 500 ng
EUR 3319

DSCAM Protein Vector (Rat) (pPM-C-His)

PV264925 500 ng
EUR 3319

Polyclonal Goat Anti-DSCAM Antibody

APG03359G 0.1 mg
EUR 484
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-DSCAM . This antibody is tested and proven to work in the following applications:

DSCAM Polyclonal Antibody, HRP Conjugated

A69472 100 ?g
EUR 628.55
Description: kits suitable for this type of research

DSCAM Polyclonal Antibody, FITC Conjugated

A69473 100 ?g
EUR 628.55
Description: fast delivery possible

DSCAM Polyclonal Antibody, Biotin Conjugated

A69474 100 ?g
EUR 628.55
Description: reagents widely cited

pECMV-Dscam-m-FLAG Plasmid

PVT15214 2 ug
EUR 325

DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV723366 1.0 ug DNA Ask for price

DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV723367 1.0 ug DNA Ask for price

DSCAM-AS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV723368 1.0 ug DNA Ask for price

DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV723372 1.0 ug DNA Ask for price

DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV723373 1.0 ug DNA Ask for price

DSCAM-IT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV723374 1.0 ug DNA Ask for price

DSCAM-IT1 Protein Vector (Human) (pPB-C-His)

PV074133 500 ng Ask for price

DSCAM-IT1 Protein Vector (Human) (pPB-N-His)

PV074134 500 ng Ask for price

DSCAM-IT1 Protein Vector (Human) (pPM-C-HA)

PV074135 500 ng Ask for price

DSCAM-IT1 Protein Vector (Human) (pPM-C-His)

PV074136 500 ng Ask for price

DSCAM sgRNA CRISPR Lentivector set (Human)

K0633201 3 x 1.0 ug
EUR 339

Dscam sgRNA CRISPR Lentivector set (Mouse)

K3785001 3 x 1.0 ug
EUR 339

Dscam sgRNA CRISPR Lentivector set (Rat)

K7053401 3 x 1.0 ug
EUR 339

DSCAM sgRNA CRISPR Lentivector (Human) (Target 1)

K0633202 1.0 ug DNA
EUR 154

DSCAM sgRNA CRISPR Lentivector (Human) (Target 2)

K0633203 1.0 ug DNA
EUR 154

DSCAM sgRNA CRISPR Lentivector (Human) (Target 3)

K0633204 1.0 ug DNA
EUR 154

Dscam sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3785002 1.0 ug DNA
EUR 154

Dscam sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3785003 1.0 ug DNA
EUR 154

Dscam sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3785004 1.0 ug DNA
EUR 154

Dscam sgRNA CRISPR Lentivector (Rat) (Target 1)

K7053402 1.0 ug DNA
EUR 154

Dscam sgRNA CRISPR Lentivector (Rat) (Target 2)

K7053403 1.0 ug DNA
EUR 154

Dscam sgRNA CRISPR Lentivector (Rat) (Target 3)

K7053404 1.0 ug DNA
EUR 154

Dscam 3'UTR Luciferase Stable Cell Line

TU203644 1.0 ml Ask for price

Dscam 3'UTR GFP Stable Cell Line

TU155400 1.0 ml Ask for price

DSCAM 3'UTR Luciferase Stable Cell Line

TU006333 1.0 ml
EUR 2333

Dscam 3'UTR Luciferase Stable Cell Line

TU105400 1.0 ml Ask for price

DSCAM 3'UTR GFP Stable Cell Line

TU056333 1.0 ml
EUR 2333

Dscam 3'UTR GFP Stable Cell Line

TU253644 1.0 ml Ask for price

Down syndrome cell adhesion molecule homolog (DSCAM) Antibody

20-abx334273
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Down Syndrome Cell Adhesion Molecule Homolog (DSCAM) Antibody

abx431217-200ul 200 ul
EUR 384
  • Shipped within 1-3 working days.

Human Down syndrome cell adhesion molecule, DSCAM ELISA KIT

ELI-09255h 96 Tests
EUR 824

Down syndrome cell adhesion molecule homolog (DSCAM) Antibody (HRP)

20-abx335457
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Down syndrome cell adhesion molecule homolog (DSCAM) Antibody (FITC)

20-abx335458
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Down syndrome cell adhesion molecule homolog (DSCAM) Antibody (Biotin)

20-abx335459
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-10 working days.

Human Down Syndrome Cell Adhesion Molecule (DSCAM) ELISA Kit

abx384809-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.

Mouse Down Syndrome Cell Adhesion Molecule (DSCAM) ELISA Kit

abx389101-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.

Rat Down Syndrome Cell Adhesion Molecule (DSCAM) ELISA Kit

abx391247-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.

Dscam ELISA Kit| Rat Down syndrome cell adhesion molecule homol

EF018602 96 Tests
EUR 689

Dscam ELISA Kit| Mouse Down syndrome cell adhesion molecule hom

EF014731 96 Tests
EUR 689

DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0633205 3 x 1.0 ug
EUR 376

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3785005 3 x 1.0 ug
EUR 376

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7053405 3 x 1.0 ug
EUR 376

DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0633206 1.0 ug DNA
EUR 167

DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0633207 1.0 ug DNA
EUR 167

DSCAM sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0633208 1.0 ug DNA
EUR 167

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3785006 1.0 ug DNA
EUR 167

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3785007 1.0 ug DNA
EUR 167

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3785008 1.0 ug DNA
EUR 167

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7053406 1.0 ug DNA
EUR 167

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7053407 1.0 ug DNA
EUR 167

Dscam sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7053408 1.0 ug DNA
EUR 167

Cas9 Nuclease Lentiviral Vector

K002 10 ug
EUR 154

Cas9 Nickase Lentiviral Vector

K005 10 ug
EUR 154

dCas9-KRAB Lentiviral Vector

K203 10 ug
EUR 228

pLenti-GFP Lentiviral Control Vector

LTV-400 100 µL
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW-MNDnLacZ Lentiviral Control Vector

LTV-402 10 µg
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW-Puro Lentiviral Expression Vector

VPK-212 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-Neo Lentiviral Expression Vector

VPK-213 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-Hygro Lentiviral Expression Vector

VPK-214 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-GFP-Puro Lentiviral Control Vector

LTV-401 10 µg
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pLenti-RFP-Puro Lentiviral Control Vector

LTV-403 100 µL
EUR 618
Description: Use this control vector to co-transfect along with lentivirus packaging vectors to make a recombinant control lentivirus.

pSMPUW-GFP-LC3 Lentiviral Expression Vector

LTV-801 10 µg
EUR 1204
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included.

ESR1 Lentiviral Vector (Human) (pLenti-II)

LV010008 1.0 ug DNA
EUR 316

pSMPUW Universal Lentiviral Expression Vector (Promoterless)

VPK-211 10 µg
EUR 624
Description: Clone your gene of interest and a gene-specific promoter into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293T or 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Puro Lentiviral Expression Vector

VPK-215 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Neo Lentiviral Expression Vector

VPK-216 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Hygro Lentiviral Expression Vector

VPK-217 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

pSMPUW-IRES-Blasticidin Lentiviral Expression Vector

VPK-219 10 µg
EUR 624
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer.

PLEKHG5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662599 1.0 ug DNA
EUR 1355

PLEKHG5 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662603 1.0 ug DNA
EUR 1355

PLEKHG5 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662604 1.0 ug DNA
EUR 1355

ZBTB44 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662605 1.0 ug DNA
EUR 682

ZBTB44 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662609 1.0 ug DNA
EUR 682

ZBTB44 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662610 1.0 ug DNA
EUR 682

GAS8 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662611 1.0 ug DNA
EUR 682

GAS8 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662615 1.0 ug DNA
EUR 682

GAS8 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662616 1.0 ug DNA
EUR 682

Aldh1a7 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662617 1.0 ug DNA
EUR 682

Aldh1a7 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662621 1.0 ug DNA
EUR 682

Aldh1a7 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662622 1.0 ug DNA
EUR 682

PAN2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662623 1.0 ug DNA
EUR 1355

PAN2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662627 1.0 ug DNA
EUR 1355

PAN2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662628 1.0 ug DNA
EUR 1355

GIPC2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662629 1.0 ug DNA
EUR 514

GIPC2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662633 1.0 ug DNA
EUR 514

GIPC2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662634 1.0 ug DNA
EUR 514

SULT4A1 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662635 1.0 ug DNA
EUR 514

SULT4A1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV662639 1.0 ug DNA
EUR 514

SULT4A1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV662640 1.0 ug DNA
EUR 514

WDR5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV662641 1.0 ug DNA
EUR 682
On this overview, we offer an outline of CKD definition and staging, the subtypes of CVD most related to CKD, main pathophysiological mechanisms, and the present state of CKD as a predictor of CVD in main scientific tips. We are going to introduce the novel idea of a “CKD Add-on”, which permits the incorporation of CKD measures in current danger prediction fashions, and the implications of making an allowance for CKD within the administration of CVD danger.

Leave a Reply

Your email address will not be published. Required fields are marked *